Join Depymed at the LSX World Congress USA in Boston on September 13-14, 2023 – Let’s Talk Investments!

Welcome to the world of DepYmed! What is DepYmed? DepYmed, Inc. is a preclinical stage pharmaceutical company that is dedicated to developing groundbreaking treatments for rare diseases and oncology. Their focus lies on targeting the protein tyrosine phosphatase (PTP) family of enzymes. This approach sets them apart from other pharmaceutical companies and positions them as…

Read More

“Attention Shareholders: Pomerantz Law Firm Digs into Claims on Your Behalf! Let’s Get to the Bottom of It Together.”

Welcome to the HelloFresh Party! Investigating Claims with Pomerantz LLP Hey there, savvy investors! If you’ve been keeping an eye on HelloFresh SE, then you might have heard some buzz about an investigation being conducted by Pomerantz LLP. Don’t worry, we’ve got all the juicy details for you right here! Who is HelloFresh SE? HelloFresh…

Read More

Coca-Cola Europacific Partners PLC Delivers Exciting Q3 Trading Update and Declares Interim Dividend: A Refreshing Recap!

Trading Update for the Third Quarter ended 27 September 2024 & Interim Dividend Declaration Solid third quarter; reaffirming full-year profit & cash guidance UXBRIDGE, ENGLAND / ACCESSWIRE / November 5, 2024 / Coca-Cola Europacific Partners plc Change vs 2023 Revenue Volume (UC) Revenue per UC Comparable Volume Revenue per UC FXN revenue Europe €4,040m 695m…

Read More

Unleashing the Scoop: A Monthly Report on Bitcoin ETF Performance Trends for March

Welcome to the Wild World of Bitcoin ETFs Bitcoin ETF March Monthly Report: Insights into Performance Trends Enter the realm of Bitcoin ETFs, a burgeoning trend that recently gained significant momentum, particularly following the recent approval by the US SEC of approximately 11 Bitcoin Spot ETFs. The monthly analysis, which delves deep into the performance…

Read More

Attention Investors: Deadline Approaching for MDRX Lawsuit – Take Action Now with Robbins Geller Rudman & Dowd LLP

MDRX Investor Deadline Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. San Diego, Nov. 27, 2023 (GLOBE NEWSWIRE) The law firm of Robbins Geller Rudman & Dowd LLP has announced that purchasers of Veradigm Inc. (NASDAQ: MDRX) common stock between February 26, 2021 and June 13, 2023, have an opportunity…

Read More

Unveiling the Power of BriaCell: Positive Overall Survival Data for All Patient Subtypes in Metastatic Breast Cancer to be Showcased at 2024 SABCS

BriaCell Therapeutics Corp. to Highlight Positive Data at SABCS 2024 Overview PHILADELPHIA and VANCOUVER, British Columbia, Nov. 26, 2024 – BriaCell Therapeutics Corp. announced that it will be showcasing its encouraging overall survival and clinical benefit data from metastatic breast cancer patients, including those with CNS metastasis, at the 2024 San Antonio Breast Cancer Symposium®….

Read More